Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice

G. A. Filice, Claire Pomeroy

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Clindamycin was used to treat the reactivation of a chronic Toxoplasma gondii infection in mice. Clindamycin reduced mortality by 44% when used prophylactically (P < 0.001) but appeared to be less effective when used to treat clinically apparent reactivation. Further studies should be conducted to establish the efficacy of clindamycin for the treatment of toxoplasmosis in humans.

Original languageEnglish (US)
Pages (from-to)780-782
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume35
Issue number4
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Effect of clindamycin on pneumonia from reactivation of Toxoplasma gondii infection in mice'. Together they form a unique fingerprint.

Cite this